Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from MD Anderson is evaluating chemotherapy and radiation therapy for IDH-wildtype gliomas and non-histological (molecular) glioblastom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma | Phase 2 | Status: RECRUITING